Why the study?
Does MitraClip therapy have similar procedural success and 30-day outcomes in patients with functional versus degenerative mitral regurgitation?
Does MitraClip therapy have similar procedural success and 30-day outcomes in patients with functional versus degenerative mitral regurgitation?
MitraClip therapy demonstrates similar safety, procedural success, and clinical benefit at 30 days for both functional and degenerative mitral regurgitation in an Asia-Pacific cohort.
No takes yet. Share an insight, caveat, or question.
Supports similar short-term MitraClip outcomes across MR types in this cohort; leaves open randomized confirmation before broader adoption.
Tay et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: